Lumax Pharmaceutical Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.50 M
- Company Age 36 Year, 2 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 5.20 M
- Revenue Growth %
- Net Worth 4.34%
- Total Assets -0.14%
About Lumax Pharmaceutical Laboratories
Lumax Pharmaceutical Laboratories Private Limited (LPLPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 November 1988 and has a history of 36 years and two months. Its registered office is in U T, Chandigarh.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹5.20 M.
Dhruv Sharma and Manju Sharma serve as directors at the Company.
Company Details
-
LocationU T, Chandigarh
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231CH1988PTC008835
-
Company No.
008835
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Nov 1988
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
What products or services does Lumax Pharmaceutical Laboratories Private Limited offer?
Lumax Pharmaceutical Laboratories Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Antacid Drugs, Anti Infective Drugs & Medicines, Antiparasitic Drug, Antibiotic Tablets, Capsule & Syrup, Pantoprazole Drugs, Pantoprazole & Domperidone Capsules, Dicyclomine Hydrochloride Medicine, Antifungal Cream, Ointment & Powder, Terbinafine Hydrochloride Cream.
Who are the key members and board of directors at Lumax Pharmaceutical Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dhruv Sharma
|
Additional Director | 05-Jan-2023 | Current |
|
Manju Sharma
|
Additional Director | 11-Jan-2016 | Current |
Financial Performance of Lumax Pharmaceutical Laboratories.
Lumax Pharmaceutical Laboratories Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth moved up by a moderate rise of 4.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lumax Pharmaceutical Laboratories?
In 2017, Lumax Pharmaceutical Laboratories had a promoter holding of 51.53% and a public holding of 48.47%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹5.20 M
₹0
Charges Breakdown by Lending Institutions
- Punjab National Bank : 0.52 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Sep 2009 | Punjab National Bank | ₹2.45 M | Open |
| 25 Sep 2009 | Punjab National Bank | ₹2.75 M | Open |
How Many Employees Work at Lumax Pharmaceutical Laboratories?
Unlock and access historical data on people associated with Lumax Pharmaceutical Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lumax Pharmaceutical Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lumax Pharmaceutical Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
